Overview of the 340B Drug Pricing Program

General 2015). In response, HRSA plans to develop a website to share ceiling prices with
340B providers. However, HRSA lacks statutory authority to share ceiling prices with state
Medicaid programs.
28 Medicare spending includes program spending and beneficiary cost sharing for separately
payable Part B chemotherapy drugs and drug administration services. The analysis includes
hospitals paid under the outpatient prospective payment system as well as critical access
hospitals, but excludes hospitals in Maryland.
29 In addition, hospitals (except CAHs) must have a minimum DSH adjustment percentage to
be eligible for 340B.
30 HRSA requires a state or local government official and a hospital executive to certify that a
contract exists, but does not require the hospital to submit it to HRSA for review.
Overview of the 340B Drug Pricing Program | May 2015 21